{{Rsnum
|rsid=10636
|Gene=MT2A
|Chromosome=16
|position=56609431
|Orientation=plus
|GMAF=0.2429
|Gene_s=MT2A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 4.6 | 41.5 | 53.8
| HCB | 11.1 | 33.3 | 55.6
| JPT | 2.3 | 34.1 | 63.6
| YRI | 9.5 | 38.1 | 52.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 33.3 | 55.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22824183
|Title=Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population
}}{{PMID Auto
|PMID=18349110
|Title=Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications.
}}

{{PMID Auto
|PMID=22233731
|Title=An investigation of modifying effects of metallothionein single-nucleotide polymorphisms on the association between mercury exposure and biomarker levels.
|OA=1
}}

{{PMID Auto
|PMID=22391096
|Title=Bone mineral density and polymorphisms in metallothionein 1A and 2A in a Chinese population exposed to cadmium.
}}
{{PMID Auto
|PMID=22995156
|Title=A Polymorphism in Metallothionein 1A (MT1A) is associated with Cadmium-related excretion of urinary Beta-2 microglobulin
}}
{{PMID Auto
|PMID=23053628
|Title=Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer
|OA=1
}}
{{PMID Auto
|PMID=23827881
|Title=Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children
}}
{{PMID Auto
|PMID=24952512
|Title=Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population
}}